Press Release: Novartis expands Zolgensma -2-

For Novartis multimedia content, please visit https://www.novartis.com/news/media-library https://www.novartis.com/news/media-library

For questions about the site or required registration, please contact media.relations@novartis.com

References

1. Anderton RS and Mastaglia FL. Expert Rev Neurother. 2015;15(8):895--908.

2. Finkel RS, McDermott MP, Kaufmann P. et al. Neurology. 2014;83(9):810-7.

3. Novartis. 2021. Q4 2021 Results Investor presentation [PowerPoint

Presentation]. Available

at: https://www.novartis.com/sites/novartis_com/files/q4-2021-investor-pr

esentation.pdf. Accessed March 2022.

4. Sugarman EA, Nagan N, Zhu H, et al. Eur J Hum Genet. 2012;20(1):27-32.

5. Lorson CL, Rindt H, Shababi M. Hum Mol Genet. 2010;(15):111-8.

6. Verhaart IEC, Robertson A, Wilson IJ, et al. Orphanet J Rre Dis.

2017;4;12(1):124.

7. Feldkötter M, et al. Am J Hum Genet. 2002;70:358--68.

8. Darras BT, Finkel RS. "Natural history of spinal muscular atrophy." In:

Sumner CJ, Paushkin S, Ko CP, eds. Spinal Muscular Atrophy: Disease

Mechanisms and Therapy, 2nd ed. London, UK: Academic

Press/Elsevier;2017:399--421.

9. Soler--Botija C, et al. Brain. 2002;125(7):1624-1634.

10. Glascock J, Sampson J, Haidet-Phillips A, et al. J Neuromuscul Dis.

2018;5:145-158.

# # #

Novartis Media Relations

E-mail: media.relations@novartis.com

Anja von Treskow Erin Gardiner

Novartis External Communications Novartis Gene Therapies Communications

+41 79 392 8697 (mobile) +1 773 655 1001 (mobile)

anja.von_treskow@novartis.com erin.gardiner@novartis.com

Julie Masow

Novartis US External Communications

+1 862 579 8456

julie.masow@novartis.com

Novartis Investor Relations

Central investor relations line: +41 61 324 7944

E-mail: investor.relations@novartis.com

Central North America

Samir Shah +41 61 324 7944 Sloan Simpson +1 862 345 4440

Nicole Zinsli-Somm +4 16 132 43809 Alina Levchuk +1 862 778 3372

Isabella Zinck +41 61 324 7188 Parag Mahanti +1 973-876-4912

(END) Dow Jones Newswires

April 05, 2022 01:15 ET (05:15 GMT)